Stroke Outcomes in the Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) Trial

Archive ouverte

Sharma, Mukul, M | Ha, Robert | Connolly, Stuart | Bosch, Jackie | Shestakovska, Olga | Ng, Kelvin | Ha, Luciana | Keltai, Katalin | Aboyans, Victor | Alings, Marco | Ha, Jong-Won | Varigos, John | Tonkin, Andrew | O'Donnell, Martin | Bhatt, Deepak | Fox, Keith, A.A. | Maggioni, Aldo | Berkowitz, Scott | Cook Bruns, Nancy | Yusuf, Salim | Eikelboom, John | Hart, Robert | Ng, Kelvin K.H. | Catanese, Luciana | Ha, Deepak | Ha, Salim

Edité par CCSD ; American Heart Association -

International audience. Strokes were significantly reduced by the combination of rivaroxaban plus aspirin compared with aspirin in the COMPASS Trial. We present detailed analyses of stroke by type, predictors, and antithrombotic effects in key subgroups. . URL: https://www.clinicaltrials.gov Unique Identifier: NCT01776424.

Consulter en ligne

Suggestions

Du même auteur

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Archive ouverte | Anand, Sonia | CCSD

International audience. BACKGROUND:Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these complications.METHODS:...

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

Archive ouverte | Eikelboom, John | CCSD

International audience. BACKGROUND:We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention.METHODS:In this double-blin...

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial

Archive ouverte | Eikelboom, John | CCSD

International audience. Abstract Aims To describe outcomes of patients with chronic coronary artery disease (CAD) and/or peripheral artery disease (PAD) enrolled in The Cardiovascular Outcomes for People Using Antic...

Chargement des enrichissements...